During the pandemic, decentralized clinical trials became more and more relevant. With moving away from on-site trials, this new trend changes the reality of big and complex data management, the use of artificial intelligence tools and new regulatory frameworks. How do we manage gathering, storage and processing of data in a decentralized environment? The community still discusses the full application of CTIS and the regulatory application.
At the Clinical Trials and Data Science Conference, decision-makers across the industry, regulatory and patient organizations will meet to discuss the future of clinical trials to find innovative solutions.
Bhausaheb Patil,
Head of Business Operations, Decentralized Clinical Trials Solutions at IQVIA
Session details to follow.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
.svg){kind=icon}
